Unio Capital LLC Grows Stake in Intuitive Surgical, Inc. $ISRG

Unio Capital LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 67,943 shares of the medical equipment provider’s stock after acquiring an additional 1,705 shares during the quarter. Intuitive Surgical comprises about 5.1% of Unio Capital LLC’s investment portfolio, making the stock its 11th biggest position. Unio Capital LLC’s holdings in Intuitive Surgical were worth $27,019,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Main Street Group LTD bought a new position in shares of Intuitive Surgical during the 1st quarter valued at approximately $30,000. Compass Financial Management LLC bought a new stake in Intuitive Surgical in the second quarter worth $30,000. Vermillion Wealth Management Inc. lifted its position in Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the last quarter. Motiv8 Investments LLC purchased a new position in Intuitive Surgical during the fourth quarter worth $34,000. Finally, Evergreen Advisors LLC bought a new position in Intuitive Surgical during the first quarter valued at $35,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ISRG has been the subject of several analyst reports. Truist Financial lowered their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research note on Tuesday, June 2nd. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. TD Cowen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Finally, The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a report on Wednesday, May 27th. Twenty-two analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $369.25 on Wednesday. The stock has a market cap of $130.45 billion, a price-to-earnings ratio of 42.30, a PEG ratio of 2.72 and a beta of 1.47. The firm’s 50-day moving average is $383.40 and its two-hundred day moving average is $430.61. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the previous year, the business posted $1.81 EPS. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. On average, equities analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares in the company, valued at $498,271,600. This represents a 0.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the director directly owned 251 shares in the company, valued at $95,129. This trade represents a 61.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 11,658 shares of company stock worth $4,649,835. 0.60% of the stock is currently owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.